{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:39:34Z","timestamp":1648777174613},"reference-count":37,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["openophthalmologyjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOOPHTJ"],"published-print":{"date-parts":[[2018,6,29]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                        The study aimed to evaluate iris thickness changes in patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) under treatment with Prostaglandin Analogues (PG).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Primary outcome measures were iris thickness at the region of Dilator Muscle Region (DMR) and Sphincter Muscle Region (SMR). DMR\/SMR ratio was also evaluated. The secondary outcome was the correlation between PG treatment length and iris parameters.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The charts of patients with POAG or OHT who underwent Visante OCT were retrospectively selected. The patients were divided in a group using PG for at least 6 months and a group using hypotensive drops not including PG or alpha-adrenergic agonists. A third group included healthy subjects.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>98 subjects were selected. Patients with POAG or OHT using PG eyedrops showed a significant iris thickness reduction at DMR compared to healthy subjects and to patients using hypotensive eyedrops not containing PG. Significantly higher SMR thickness values were found in PG group compared to both control groups. DMR\/SMR ratio significantly reduced in PG group. No correlation was found between PG treatment length and iris parameters.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present data indicate that PG treatment induced DMR thickness reduction and an increase in SMR thickness. These changes were not related to the duration of PG exposure.<\/jats:p>\n                <\/jats:sec>","DOI":"10.2174\/1874364101812010110","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T05:15:21Z","timestamp":1531113321000},"page":"110-120","update-policy":"http:\/\/dx.doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension"],"prefix":"10.2174","volume":"12","author":[{"given":"R","family":"Mancino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorge","family":"RP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cesareo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.pbr.2015.04.010","volume":"221","author":"Nucci C.","year":"2015","unstructured":"Nucci C, Martucci A, Cesareo M, et al. \n                    Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system. \n                    Prog Brain Res  \n                    2015; \n                    221\n                    : 49-65.","journal-title":"Prog. Brain Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0079-6123(08)01107-2","volume":"173","author":"Scuderi G.L.","year":"2008","unstructured":"Scuderi GL, Cesareo M, Perdicchi A, Recupero SM. \n                    Standard automated perimetry and algorithms for monitoring glaucoma progression. \n                    Prog Brain Res  \n                    2008; \n                    173\n                    : 77-99.","journal-title":"Prog. Brain Res."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2147\/OPTH.S113995","volume":"10","author":"Perdicchi A.","year":"2016","unstructured":"Perdicchi A, Abdolrahimzadeh S, Cutini A, Ciarnella A, Scuderi GL. \n                    Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma. \n                    Clin Ophthalmol  \n                    2016; \n                    10\n                    : 1647-51.","journal-title":"Clin. Ophthalmol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0161-6420(99)90497-9","volume":"106","author":"Leske M.C.","year":"1999","unstructured":"Leske MC, Heijl A, Hyman L, Bengtsson B. \n                    Early manifest glaucoma Trial: Design and baseline data. \n                    Ophthalmology  \n                    1999; \n                    106\n                    (11)\n                    : 2144-53.","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0161-6420(99)90497-9","volume":"120","year":"2002","unstructured":"HeiJl AH. \n                    Reduction of intraocular pressure and glaucoma progression. Results from the early manifest glaucoma trial. \n                    Arch Ophthalmol  \n                    2002; \n                    120\n                    : 1268-79.","journal-title":"Arch Ophthalmol."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003167.pub3","volume":"17","author":"Vass C","year":"2007","unstructured":"Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L. \n                    Medical interventions for primary open angle glaucoma and ocular hypertension.  \n                    Cochrane Database Syst Rev  \n                    2007; \n                    17\n                    (4)","journal-title":"Cochrane Database Syst Rev."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ophtha.2007.10.004","volume":"115","author":"Stewart W.C.","year":"2008","unstructured":"Stewart WC, Konstas AG, Nelson LA, Kruft B. \n                    Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. \n                    Ophthalmology  \n                    2008; \n                    115\n                    (7)\n                    : 1117-1122.e1.","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"van der Valk R.","year":"2005","unstructured":"van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH. \n                    Intraocular pressure-lowering effects of all commonly used glaucoma drugs: A meta-analysis of randomized clinical trials. \n                    Ophthalmology  \n                    2005; \n                    112\n                    (7)\n                    : 1177-85.","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","volume":"53","author":"Alm A.","year":"2008","unstructured":"Alm A, Grierson I, Shields MB. \n                    Side effects associated with prostaglandin analog therapy. \n                    Surv Ophthalmol  \n                    2008; \n                    53\n                    (Suppl. 1)\n                    : S93-S105.","journal-title":"Surv. Ophthalmol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14740338.6.1.45","volume":"6","author":"Holl\u00f3 G.","year":"2007","unstructured":"Holl\u00f3 G. \n                    The side effects of the prostaglandin analogues. \n                    Expert Opin Drug Saf  \n                    2007; \n                    6\n                    (1)\n                    : 45-52.","journal-title":"Expert Opin. Drug Saf."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/S0039-6257(02)00304-1","volume":"47","author":"Grierson I.","year":"2002","unstructured":"Grierson I, Pfeiffer N, Cracknell KP, Appleton P. \n                    Histology and fine structure of the iris and outflow system following latanoprost therapy. \n                    Surv Ophthalmol  \n                    2002; \n                    47\n                    (Aug)\n                    (Suppl. 1)\n                    : S176-84.","journal-title":"Surv. Ophthalmol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/S0039-6257(97)80020-3","volume":"41","author":"Wistrand P.J.","year":"1997","unstructured":"Wistrand PJ, Stjernschantz J, Olsson K. \n                    The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. \n                    Surv Ophthalmol  \n                    1997; \n                    41\n                    (Feb)\n                    (Suppl. 2)\n                    : S129-38.","journal-title":"Surv. Ophthalmol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00055735-200104000-00006","volume":"12","author":"Grierson I.","year":"2001","unstructured":"Grierson I, Cracknell KP, Pfeiffer N. \n                    The iris after prostanoid treatment. \n                    Curr Opin Ophthalmol  \n                    2001; \n                    12\n                    (2)\n                    : 112-8.","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/exer.1998.0581","volume":"68","author":"Drago F.","year":"1999","unstructured":"Drago F, Marino A, La Manna C. \n                    Alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro. \n                    Exp Eye Res  \n                    1999; \n                    68\n                    (1)\n                    : 85-90.","journal-title":"Exp. Eye Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/vop.12011","volume":"16","author":"Tsai S.","year":"2013","unstructured":"Tsai S, Almazan A, Lee SS, et al. \n                    The effect of topical latanoprost on anterior segment anatomic relationships in normal dogs. \n                    Vet Ophthalmol  \n                    2013; \n                    16\n                    (5)\n                    : 370-6.","journal-title":"Vet. Ophthalmol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1167\/iovs.07-1477","volume":"49","author":"Leung C.K.","year":"2008","unstructured":"Leung CK, Li H, Weinreb RN, et al. \n                    Anterior chamber angle measurement with anterior segment optical coherence tomography: A comparison between slit lamp OCT and Visante OCT. \n                    Invest Ophthalmol Vis Sci  \n                    2008; \n                    49\n                    (8)\n                    : 3469-74.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/112067211002000327","volume":"20","author":"Dinc U.A.","year":"2010","unstructured":"Dinc UA, Oncel B, Gorgun E, Yalvac IS. \n                    Assessment of anterior chamber angle using Visante OCT, slit-lamp OCT, and Pentacam. \n                    Eur J Ophthalmol  \n                    2010; \n                    20\n                    (3)\n                    : 531-7.","journal-title":"Eur. J. Ophthalmol."},{"key":"ref18","unstructured":"Terminology and guidelines for Glaucoma, 3rd Edition. European Glaucoma Society."},{"key":"ref19","unstructured":"Carl Zeiss Meditec. Visante OCT User Manual. 4-8\u20134-9. 2006."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ophtha.2008.12.040","volume":"116","author":"Prata T.S.","year":"2009","unstructured":"Prata TS, Palmiero PM, Angelilli A, et al. \n                    Iris morphologic changes related to alpha (1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome. \n                    Ophthalmology  \n                    2009; \n                    116\n                    (5)\n                    : 877-81.","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ophtha.2005.01.022","volume":"112","author":"Leung C.K.","year":"2005","unstructured":"Leung CK, Chan WM, Ko CY, et al. \n                    Visualization of anterior chamber angle dynamics using optical coherence tomography. \n                    Ophthalmology  \n                    2005; \n                    112\n                    (6)\n                    : 980-4.","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1755-3768.2008.01417.x","volume":"88","author":"Prata T.S.","year":"2010","unstructured":"Prata TS, De Moraes CG, Palmiero PM, Tello C, Liebmann J, Ritch R. \n                    Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb. \n                    Acta Ophthalmol  \n                    2010; \n                    88\n                    (8)\n                    : 910-1.","journal-title":"Acta Ophthalmol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00004397-200404420-00004","volume":"44","author":"Nguyen Q.H.","year":"2004","unstructured":"Nguyen QH. \n                    The role of prostaglandin analogues in the treatment of glaucoma in the 21st century. \n                    Int Ophthalmol Clin  \n                    2004; \n                    44\n                    (2)\n                    : 15-27.","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/S0039-6257(02)00292-8","volume":"47","author":"Stjernschantz J.W.","year":"2002","unstructured":"Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ. \n                    Mechanism and clinical significance of prostaglandin-induced iris pigmentation. \n                    Surv Ophthalmol  \n                    2002; \n                    47\n                    (Suppl. 1)\n                    : S162-75.","journal-title":"Surv. Ophthalmol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00061198-200110000-00009","volume":"10","author":"Tsai J.C.","year":"2001","unstructured":"Tsai JC, Sivak-Callcott JA, Haik BG, Zhang J, McLean IW. \n                    Latanoprost-induced iris heterochromia and open-angle glaucoma: A clinicopathologic report. \n                    J Glaucoma  \n                    2001; \n                    10\n                    (5)\n                    : 411-3.","journal-title":"J. Glaucoma"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/archopht.122.11.1680","volume":"122","author":"Albert D.M.","year":"2004","unstructured":"Albert DM, Gangnon RE, Zimbric ML, et al. \n                    A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients. \n                    Arch Ophthalmol  \n                    2004; \n                    122\n                    (11)\n                    : 1680-5.","journal-title":"Arch. Ophthalmol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ajo.2004.06.017","volume":"138","author":"Arranz-Marquez E.","year":"2004","unstructured":"Arranz-Marquez E, Teus MA, Saornil MA, Mendez MC, Gil R. \n                    Analysis of irises with a latanoprost-induced change in iris color. \n                    Am J Ophthalmol  \n                    2004; \n                    138\n                    (4)\n                    : 625-30.","journal-title":"Am. J. Ophthalmol."},{"key":"ref28","first-page":"191","volume":"119","author":"Pfeiffer N.","year":"2001","unstructured":"Pfeiffer N, Grierson I, Goldsmith H, Hochgesand D, Winkgen-B\u00f6hres A, Appleton P. \n                    Histological effects in the iris after 3 months of latanoprost therapy: The Mainz 1 study. \n                    Arch Ophthalmol  \n                    2001; \n                    119\n                    (2)\n                    : 191-6.","journal-title":"Arch. Ophthalmol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/archopht.121.1.23","volume":"121","author":"Pfeiffer N.","year":"2003","unstructured":"Pfeiffer N, Grierson I, Goldsmith H, Appleton P, Hochgesand D, Winkgen A. \n                    Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study). \n                    Arch Ophthalmol  \n                    2003; \n                    121\n                    (1)\n                    : 23-31.","journal-title":"Arch. Ophthalmol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ophtha.2006.10.025","volume":"114","author":"Cracknell K.P.","year":"2007","unstructured":"Cracknell KP, Grierson I, Hogg P. \n                    Morphometric effects of long-term exposure to latanoprost. \n                    Ophthalmology  \n                    2007; \n                    114\n                    (5)\n                    : 938-48.","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archopht.126.5.626","volume":"126","author":"Albert D.M.","year":"2008","unstructured":"Albert DM, Gangnon RE, Grossniklaus HE, Green WR, Darjatmoko S, Kulkarni AD. \n                    A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. \n                    Arch Ophthalmol  \n                    2008; \n                    126\n                    (5)\n                    : 626-31.","journal-title":"Arch. Ophthalmol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s003470070087","volume":"97","author":"Dinslage S.","year":"2000","unstructured":"Dinslage S, Diestelhorst M, K\u00fchner H, Krieglstein GK. \n                    The effect of latanoprost 0.005% on pupillary reaction of the human eye. \n                    Ophthalmologe  \n                    2000; \n                    97\n                    (6)\n                    : 396-401.","journal-title":"Ophthalmologe"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00061198-200302000-00011","volume":"12","author":"Kurtz S.","year":"2003","unstructured":"Kurtz S, Leibovitch I, Shemesh G, Rothkoff L, Loewenstein A. \n                    The effect of latanoprost on accommodation in young patients with ocular hypertension. \n                    J Glaucoma  \n                    2003; \n                    12\n                    (1)\n                    : 54-6.","journal-title":"J. Glaucoma"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s10792-014-9920-1","volume":"34","author":"Martucci A.","year":"2014","unstructured":"Martucci A, Cesareo M, Napoli D, et al. \n                    Evaluation of pupillary response to light in patients with glaucoma: A study using computerized pupillometry. \n                    Int Ophthalmol  \n                    2014; \n                    34\n                    (6)\n                    : 1241-7.","journal-title":"Int. Ophthalmol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0002-9394(71)90410-7","volume":"71","author":"Loewenfeld I.E.","year":"1971","unstructured":"Loewenfeld IE, Newsome DA. \n                    Iris mechanics. I. Influence of pupil size on dynamics of pupillary movements. \n                    Am J Ophthalmol  \n                    1971; \n                    71\n                    (1 Pt 2)\n                    : 347-62.","journal-title":"Am. J. Ophthalmol."},{"key":"ref36","first-page":"234","volume":"107","author":"Flach A.J.","year":"2009","unstructured":"Flach AJ. \n                    Intraoperative floppy iris syndrome: Pathophysiology, prevention, and treatment. \n                    Trans Am Ophthalmol Soc  \n                    2009; \n                    107\n                    : 234-9.","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jcrs.2013.10.031","volume":"40","author":"Shtein R.M.","year":"2014","unstructured":"Shtein RM, Hussain MT, Cooney TM, Elner VM, Hood CT. \n                    Effect of tamsulosin on iris vasculature and\u00a0morphology. \n                    J Cataract Refract Surg  \n                    2014; \n                    40\n                    (5)\n                    : 793-8.","journal-title":"J. Cataract Refract. Surg."}],"container-title":["The Open Ophthalmology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openophthalmologyjournal.com\/contents\/volumes\/V12\/TOOPHTJ-12-110\/TOOPHTJ-12-110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openophthalmologyjournal.com\/contents\/volumes\/V12\/TOOPHTJ-12-110\/TOOPHTJ-12-110.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openophthalmologyjournal.com\/contents\/volumes\/V12\/TOOPHTJ-12-110\/TOOPHTJ-12-110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T06:33:40Z","timestamp":1555310020000},"score":1,"resource":{"primary":{"URL":"https:\/\/openophthalmologyjournal.com\/VOLUME\/12\/PAGE\/110\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,6,29]]}},"alternative-id":["TOOPHTJ-12-110"],"URL":"https:\/\/doi.org\/10.2174\/1874364101812010110","relation":{},"ISSN":["1874-3641"],"issn-type":[{"value":"1874-3641","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-3-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-5-3","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-6-4","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}